Eph receptors and ephrins in cancer progression

EB Pasquale - Nature Reviews Cancer, 2024 - nature.com
Evidence implicating Eph receptor tyrosine kinases and their ephrin ligands (that together
make up the 'Eph system') in cancer development and progression has been accumulating …

Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin

D Delgado-Bellido, S Serrano-Saenz… - Molecular cancer, 2017 - Springer
Vasculogenic mimicry (VM) is a blood supply system independent of endothelial vessels in
tumor cells from different origins. It reflects the plasticity of aggressive tumor cells that …

A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion

HG Møller, AP Rasmussen, HH Andersen… - Molecular …, 2013 - Springer
Glioblastoma multiforme (GBM) is an incurable form of brain cancer with a very poor
prognosis. Because of its highly invasive nature, it is impossible to remove all tumor cells …

MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics

A Shea, V Harish, Z Afzal, J Chijioke, H Kedir… - Cancer …, 2016 - Wiley Online Library
Glioblastoma multiforme (GBM) is the most common and lethal cancer of the adult brain,
remaining incurable with a median survival time of only 15 months. In an effort to identify …

The EphA2 receptor drives self-renewal and tumorigenicity in stem-like tumor-propagating cells from human glioblastomas

E Binda, A Visioli, F Giani, G Lamorte, M Copetti… - Cancer cell, 2012 - cell.com
In human glioblastomas (hGBMs), tumor-propagating cells with stem-like characteristics
(TPCs) represent a key therapeutic target. We found that the EphA2 receptor tyrosine kinase …

Celastrol suppresses glioma vasculogenic mimicry formation and angiogenesis by blocking the PI3K/Akt/mTOR signaling pathway

Y Zhu, X Liu, P Zhao, H Zhao, W Gao… - Frontiers in …, 2020 - frontiersin.org
Angiogenesis and vasculogenic mimicry (VM) are thought to be the predominant processes
ensuring tumor blood supply during the growth and metastasis of glioblastoma (GBM) …

Vasculogenic mimicry, a complex and devious process favoring tumorigenesis–interest in making it a therapeutic target

L Treps, S Faure, N Clere - Pharmacology & therapeutics, 2021 - Elsevier
Tumor cell vasculogenic mimicry (VM), also dubbed vascular mimicry, describes the
plasticity of aggressive cancer cells forming de novo vascular networks and is associated …

[HTML][HTML] Exosomes derived from microRNA-199a-overexpressing mesenchymal stem cells inhibit glioma progression by down-regulating AGAP2

L Yu, S Gui, Y Liu, X Qiu, G Zhang, X Zhang… - Aging (Albany …, 2019 - ncbi.nlm.nih.gov
Accumulating evidence has implied that microRNAs (miRNAs) are implicated in glioma
progression, and genetically engineered mesenchymal stem cells can help to inhibit tumor …

CAR T cells: engineered immune cells to treat brain cancers and beyond

Z Huang, S Dewanjee, P Chakraborty, NK Jha, A Dey… - Molecular cancer, 2023 - Springer
Malignant brain tumors rank among the most challenging type of malignancies to manage.
The current treatment protocol commonly entails surgery followed by radiotherapy and/or …

Current progress on understanding microRNAs in glioblastoma multiforme

M Karsy, E Arslan, F Moy - Genes & cancer, 2012 - journals.sagepub.com
Glioblastoma multiforme (GBM) is an aggressive grade IV astrocytoma with a 1-year median
survival rate despite current treatment modalities. A thorough understanding of the vast …